Story perspectives
Judges Question FDA Mifepristone Telehealth Rules in Louisiana Case
9/10/2026
1 of 4
Louisiana Sues FDA
- Louisiana sued the FDA over telehealth and mail-order mifeprone rules, arguing before the 5th Circuit Court of Appeals in New Orleans this week.
- Attorney General Rob Bonta of California and attorneys general from 21 states and D.C. filed a brief saying Louisiana’s suit favors ban-state over access-state policies.
- Louisiana claims the rule undermines its abortion ban and state budget.
- Democratic officials warn in-person mandates could overwhelm clinics and delay care.
1 / 4
